Raymond James & Associates Abbott Laboratories Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Raymond James & Associates holds 3,372,735 shares of ABT stock, worth $397 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

3,372,735

Previous 3,151,958 7.0%

Holding current value

$397 Million

Previous $328 Million 17.41%

% of portfolio

0.24%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$100.07 - $118.13 $22.1 Million - $26.1 Million	220,777 Added 7.0%	3,372,735 $385 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $196,524 - $219,370	-1,951 Reduced 0.06%	3,151,958 $328 Million
Q1 2024 Apr 22, 2024	BUY	$109.52 - $120.96 $9.98 Million - $11 Million	91,118 Added 2.97%	3,153,909 $358 Million
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $887,740 - $1.09 Million	-9,843 Reduced 0.32%	3,062,791 $337 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $6.72 Million - $8.06 Million	70,355 Added 2.34%	3,072,634 $298 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $848,769 - $945,706	8,422 Added 0.28%	3,002,279 $327 Million
Q1 2023 Apr 14, 2023	SELL	$96.86 - $114.01 $10.4 Million - $12.2 Million	-106,911 Reduced 3.45%	2,993,857 $303 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $6.35 Million - $7.45 Million	-66,761 Reduced 2.11%	3,100,768 $340 Million
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $22.8 Million - $26.4 Million	235,291 Added 8.02%	3,167,529 $306 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $9.63 Million - $11.6 Million	-94,390 Reduced 3.12%	2,932,238 $319 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $2.97 Million - $3.62 Million	26,024 Added 0.87%	3,026,628 $358 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $16.8 Million - $20.5 Million	145,210 Added 5.09%	3,000,604 $422 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $12.2 Million - $13.5 Million	104,337 Added 3.79%	2,855,394 $337 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $12.6 Million - $14.8 Million	119,158 Added 4.53%	2,751,057 $319 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $28.1 Million - $33.1 Million	258,210 Added 10.88%	2,631,899 $315 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $29.4 Million - $32 Million	279,601 Added 13.35%	2,373,689 $260 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $1.01 Million - $1.23 Million	-11,014 Reduced 0.52%	2,094,088 $228 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $4.64 Million - $5.94 Million	60,620 Added 2.97%	2,105,102 $192 Million
Q1 2020 Apr 21, 2020	BUY	$62.82 - $91.86 $454,816 - $665,066	7,240 Added 0.36%	2,044,482 $161 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $4.18 Million - $4.66 Million	53,283 Added 2.69%	2,037,242 $177 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $4.1 Million - $4.45 Million	50,122 Added 2.59%	1,983,959 $166 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $6.51 Million - $7.59 Million	-89,312 Reduced 4.41%	1,933,837 $163 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $6.44 Million - $7.78 Million	-97,218 Reduced 4.58%	2,023,149 $162 Million
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $2.2 Million - $2.49 Million	33,485 Added 1.6%	2,120,367 $153 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $6.2 Million - $7.48 Million	101,959 Added 5.14%	2,086,882 $153 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $7.62 Million - $8.41 Million	132,339 Added 7.14%	1,984,923 $121 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $4.66 Million - $5.27 Million	-82,888 Reduced 4.28%	1,852,584 $111 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $22.1 Million - $23.7 Million	-412,249 Reduced 17.56%	1,935,472 $110 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $2.72 Million - $3.04 Million	56,651 Added 2.47%	2,347,721 $125 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,291,070	2,291,070 $111 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Abbott Laboratories Transaction History